cellular
N |
• 3 and 5 days after immunization, there is no evidence of increased B cell apoptosis relative to wild-type
|
• mutant B cells in mice challenged with a T1-2 antigen (NP-Ficoll) undergo rapid proliferative expansion (from 3 to 14% of lymphocytes by 5 days after immunization
• in immunized mice, on day 2 there is a higher percentage of low-affinity B cells (20%) compared to wild-type cells (~3%)
|
immune system
• mutant B cells in mice challenged with a T1-2 antigen (NP-Ficoll) undergo rapid proliferative expansion (from 3 to 14% of lymphocytes by 5 days after immunization
• in immunized mice, on day 2 there is a higher percentage of low-affinity B cells (20%) compared to wild-type cells (~3%)
|
• 4-hydroxy-3-nitrophenyl)acetyl-specific (NP) IgM antibody production is greater than in wild-type
|
• NP-specific IgM antibody production is greater than in wild-type
|
hematopoietic system
• mutant B cells in mice challenged with a T1-2 antigen (NP-Ficoll) undergo rapid proliferative expansion (from 3 to 14% of lymphocytes by 5 days after immunization
• in immunized mice, on day 2 there is a higher percentage of low-affinity B cells (20%) compared to wild-type cells (~3%)
|
• 4-hydroxy-3-nitrophenyl)acetyl-specific (NP) IgM antibody production is greater than in wild-type
|
• NP-specific IgM antibody production is greater than in wild-type
|